Besides liver diseases, the LPA signaling pathway is also involved in pathological conditions that include chronic inflammatory disorders, fibrotic diseases, and tumor progression (Choi et al, 2010; Balupuri et al, 2018). This evidence concerns the gene LPA and neoplasm.